Trials / Recruiting
RecruitingNCT05738096
Trigeminal Evoked Responses to Improve Rhizotomy
- Status
- Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- University of Minnesota · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Trigeminal neuralgia (TGN) is a debilitating pain syndrome where electrical, shock- like jolts of pain affect the face. Trigeminal somatosensory evoked potentials (TSEPs) provide a promising modality for measuring the trigeminal sensory and nociceptive pathway by using peripheral stimulation of the trigeminal nerve (on the skin) and measuring low latency evoked potentials on the scalp (contralateral sensory cortex). While TSEPs have been measured in the past, it is not clear if implementing TSEPs into a routine neurosurgical rhizotomy procedure will be feasible. This is a prospective cohort study examining the feasibility of routinely performing TSEPs during rhizotomies for TGN.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | TSEP + rhizotomy surgery | TGN patients recruited for this study will already be undergoing percutaneous rhizotomy surgery. TSEPs will be measured at baseline prior to surgery. During the rhizotomy procedure, an electrode or balloon is placed through a metal sheath to then damage the nerve. A stylet is introduced to clear tissue from the sheath in preparation for the electrode or balloon. Prior to the final insertion of the RF electrode where the gasserian ganglion will be damaged, we will place a standard stereotactic EEG electrode (SEEG). Following damaging the nerve (clinical procedure), we will record again to measure differences in the TSEPs following cell body damage. The Neuralynx system will be used to record the potentials at 40 KHz. |
| OTHER | TSEPs recording only | TSEPS will also be recorded from healthy controls in a lab setting; all procedures for the healthy controls will be non-invasive. |
Timeline
- Start date
- 2023-11-01
- Primary completion
- 2026-11-01
- Completion
- 2026-11-01
- First posted
- 2023-02-21
- Last updated
- 2025-11-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05738096. Inclusion in this directory is not an endorsement.